Cargando…
Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test”
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701314/ https://www.ncbi.nlm.nih.gov/pubmed/33254024 http://dx.doi.org/10.1016/j.ebiom.2020.103139 |
| _version_ | 1783616468496154624 |
|---|---|
| author | Weiland, Thomas Brcic, Luka Reinholz, Markus French, Lars E. Thurnher, Dietmar |
| author_facet | Weiland, Thomas Brcic, Luka Reinholz, Markus French, Lars E. Thurnher, Dietmar |
| author_sort | Weiland, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7701314 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77013142020-12-07 Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test” Weiland, Thomas Brcic, Luka Reinholz, Markus French, Lars E. Thurnher, Dietmar EBioMedicine Letter Elsevier 2020-11-27 /pmc/articles/PMC7701314/ /pubmed/33254024 http://dx.doi.org/10.1016/j.ebiom.2020.103139 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter Weiland, Thomas Brcic, Luka Reinholz, Markus French, Lars E. Thurnher, Dietmar Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test” |
| title | Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test” |
| title_full | Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test” |
| title_fullStr | Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test” |
| title_full_unstemmed | Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test” |
| title_short | Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test” |
| title_sort | response to: “study results and related evidence do not support use of hpv16 l1 drh1 antibodies as a cancer screening test” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701314/ https://www.ncbi.nlm.nih.gov/pubmed/33254024 http://dx.doi.org/10.1016/j.ebiom.2020.103139 |
| work_keys_str_mv | AT weilandthomas responsetostudyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest AT brcicluka responsetostudyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest AT reinholzmarkus responsetostudyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest AT frenchlarse responsetostudyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest AT thurnherdietmar responsetostudyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest |